An Alzheimer's disease pathway uncovered by functional omics: the risk gene CELF1 regulates KLC1 splice variant E expression, which drives Aβ pathology
Kikuchi, M.; Viet, J.; Nagata, K.; Sato, M.; David, G.; Audic, Y.; Silverman, M. A.; Yamamoto, M.; Akatsu, H.; Hashizume, Y.; Chiba, K.; Takeda, S.; Akamine, S.; Miyamoto, T.; Uozum, R.; Gotoh, S.; Mori, K.; Ikeda, M.; Paillard, L.; Morihara, T.
Show abstract
In an era when numerous disease-associated genes have been identified, determining the molecular mechanisms of complex diseases is still difficult. The CELF1 region was identified by genome-wide association studies as an Alzheimers disease (AD) risk locus. Using transcriptomics and cross-linking and immunoprecipitation sequencing (CLIP-seq), we found that CELF1, an RNA-binding protein, binds to KLC1 RNA and regulates its splicing. Analysis of two brain banks revealed that CELF1 expression is correlated with inclusion of KLC1 exons downstream of the CELF1-binding region identified by CLIP-seq. In AD, low CELF1 levels result in high levels of KLC1 splice variant E (KLC1_vE), an amyloid-{beta} (A{beta}) pathology-driving gene product. Cell culture experiments confirmed regulation of KLC1_vE by CELF1. Analysis of mouse strains with different propensities for A{beta} accumulation confirmed that Klc1_vE drives A{beta} pathology. Using omics methods, we revealedthe molecular pathway of a complex disease supported by human and mouse genetics.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Integrative Network Analysis Reveals Novel Moderators of Aβ-Tau Interaction in Alzheimer's Disease 95%
- Behavioural and transcriptomic characterization of the comorbidity between Alzheimer s disease and Major Depression 94%
- Age, Sex and Alzheimer's disease: A longitudinal study of 3xTg-AD mice reveals sex-specific disease trajectories and inflammatory responses mirrored in postmortem brains from Alzheimer's patients 94%
Similar papers in this journal
- Rare genetic variation in Fibronectin 1 (FN1) protects against APOEe4 in Alzheimer's disease 96%
- Dysregulated coordination of MAPT exon 2 and exon 10 splicing underlies different tau pathologies in PSP and AD 96%
- Low circulating choline, a modifiable dietary factor, is associated with the pathological progression and metabolome dysfunction in Alzheimers disease. 96%
Similar papers in this journal
- Deciphering cellular transcriptional alterations in Alzheimer's disease brains 95%
- Identification of a specific APOE transcript and functional elements associated with Alzheimer's disease 94%
- Characterization of mitochondrial DNA quantity and quality in the human aged and Alzheimer’s disease brain 94%
Similar papers in this journal
- A public resource of single cell transcriptomes and multiscale networks from persons with and without Alzheimer's disease 95%
- Identification of Chlamydia pneumoniae and NLRP3 inflammasome activation in Alzheimer's disease retina 94%
- Novel brain-penetrant inhibitor of G9a methylase blocks Alzheimer’s disease proteopathology for precision medication 94%